Oral News and Research

RSS

Experts provide guidebook for surgeons dealing with head and neck neoplasms

In this unique volume, leading international experts share their experiences in the management of head and neck tumors, providing a guidebook for all surgeons dealing with head and neck neoplasms.

21 Mar 2013

DART Therapeutics develops new class of therapy for Duchenne muscular dystrophy

DART Therapeutics Inc., an innovative, new-model biotechnology firm focused on developing therapies for Duchenne muscular dystrophy, announced today that it is developing a SARM drug candidate obtained from Belgium-based Galapagos NV.

21 Mar 2013

Supreme Court considering generic drugmaker safety liability

The Supreme Court is weighing if generic drugmakers can be sued over the safety of their drugs or if federal regulators' safety approval is enough to block all such legal challenges.

21 Mar 2013

Biogen receives additional patent protection for MS drug TECFIDERA

Biogen Idec today announced that the U.S. Patent and Trademark Office has granted U.S. Patent No. 8,399,514, which offers additional protection for TECFIDERA (dimethyl fumarate), the company's oral therapeutic candidate for the treatment of multiple sclerosis.

20 Mar 2013

European Congress on Osteoporosis & Osteoarthritis to start in April

Attend the European Congress on Osteoporosis & Osteoarthritis Rome, Italy from April 17-20, 2013 and earn up to 19 European Accreditation Council for Continuing Medical Education credits.

20 Mar 2013

Research provides better understanding of microbiological factors of periodontitis

Microbes from the human mouth are telling Oak Ridge National Laboratory scientists something about periodontitis and more after they cracked the genetic code of bacteria linked to the condition.

19 Mar 2013

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor, or TKI, that is being investigated for use in patients with advanced renal cell carcinoma (RCC), or kidney cancer.

19 Mar 2013

Salivary duct access products launched by Cook Medical to offer minimally invasive options for obstructive salivary gland disease

Cook Medical has launched a suite of salivary duct access products that offer minimally invasive options for the treatment of obstructive salivary gland disease. Minimally invasive treatment of obstructive salivary gland disease can reduce the need for invasive open surgery.

18 Mar 2013

Oral Cancer Foundation encourages dental practices to offer free oral cancer screenings in April

What has the greatest impact on survival rates of oral cancer? Radiation? Chemotherapy? Perhaps surgery? The truth is none of these; rather, it is the point in time at which the disease is discovered.

18 Mar 2013

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

The following research from Columbia University Medical Center and NewYork-Presbyterian Hospital is being presented at the 65th annual meeting of the American Academy of Neurology, March 16-23, 2013, in San Diego.

18 Mar 2013

Deadline pressures could put more health exchanges in the federal government's hands

Reuters reports that if states that are pursuing their own insurance marketplaces can't keep up with the timeline, it could fall to Washington to run. Meanwhile, the Minnesota House approves legislation to set up its health exchange while advocates in Colorado press to make coverage of children's dental care mandatory in plans sold on that state's exchange.

16 Mar 2013

Luminex collaborates with Merck to design companion diagnostic device for Alzheimer’s disease

WHITEHOUSE STATION known as MSD outside the United States and Canada, and Luminex Corporation have signed a collaboration and license agreement to develop a companion diagnostic device that will be evaluated to help screen patients for recruitment into Merck's clinical development program for MK-8931, a novel oral beta amyloid precursor protein site cleaving enzyme (BACE) inhibitor and Merck's lead investigational candidate for Alzheimer's disease (AD).

From Luminex 15 Mar 2013

Results from GTx's Phase 2 clinical trial of enobosarm published online

GTx, Inc. today announced that the journal, The Lancet Oncology, has published online ahead of its April print edition the results from GTx's randomized, double-blind, placebo-controlled Phase 2 clinical trial of enobosarm to assess its effects on muscle wasting and physical function in patients with cancer.

15 Mar 2013

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

The European Commission (EC) has approved expanded options for pre-treatment prior to use of QUTENZA (8% capsaicin patch). Before application the patient may now take an oral analgesic, or the treatment area may be pre-treated with a topical anaesthetic.1 The 8% capsaicin patch is the first and only licensed high concentration (8%) capsaicin cutaneous patch for the treatment of peripheral neuropathic pain in Europe.

14 Mar 2013

Brand-name and generic drug makers join forces to challenge FTC

Brand and generic drug companies are usually at each other' throats.

13 Mar 2013

Smad7 protein protects against or heals mouth sores associated with cancer treatment

Mouse model studies show that administered genetically or topically, protein Smad7 protects against or heals mouth sores commonly associated with cancer treatment.

13 Mar 2013

New, inexpensive nano-biosensor can detect Listeria monocytogenes in food

The foodborne bacteria Listeria monocytogenes sickens about 2,500 people in the U.S. each year and many more worldwide, killing about 25-30% of those infected. Listeriosis is caused by eating food contaminated with L. monocytogenes, and current methods for detecting the bacteria are costly and time consuming.

13 Mar 2013

EDTA chelation, high-dose vitamins/minerals may provide additional benefit for MI patients

Heart attack patients given a combination of high-dose oral vitamins and minerals do not exhibit a significant reduction in recurrent cardiac events, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.

13 Mar 2013

Japan provides $2.6M to UNICEF to aid Pakistan's polio eradication program

"The Government of Japan has extended a grant of 226 million Japanese Yen (approximately US$2.62 million) to Pakistan through UNICEF for supporting the polio eradication program in Pakistan," Agence France-Presse/Dawn.com reports.

13 Mar 2013

Research: Digoxin reduces hospital admission of older, acute heart failure patients

Digoxin significantly reduces the likelihood of hospital admission due to all causes among ambulatory older patients with chronic heart failure and reduced ejection fraction, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.

13 Mar 2013

Oral News and Research

Experts provide guidebook for surgeons dealing with head and neck neoplasms

DART Therapeutics develops new class of therapy for Duchenne muscular dystrophy

Supreme Court considering generic drugmaker safety liability

Biogen receives additional patent protection for MS drug TECFIDERA

European Congress on Osteoporosis & Osteoarthritis to start in April

Research provides better understanding of microbiological factors of periodontitis

Tivozanib: an interview with Stephen L. Eck, M.D., Ph.D., Vice President, Global Oncology, Astellas Pharma US, Inc. Global Development

Salivary duct access products launched by Cook Medical to offer minimally invasive options for obstructive salivary gland disease

Oral Cancer Foundation encourages dental practices to offer free oral cancer screenings in April

Columbia University Medical Center, NewYork-Presbyterian Hospital present research works at AAN meeting

Deadline pressures could put more health exchanges in the federal government's hands

Luminex collaborates with Merck to design companion diagnostic device for Alzheimer’s disease

Results from GTx's Phase 2 clinical trial of enobosarm published online

Pre-treatments for peripheral neuropathic pain patch receive European Commision approval

Brand-name and generic drug makers join forces to challenge FTC

Smad7 protein protects against or heals mouth sores associated with cancer treatment

New, inexpensive nano-biosensor can detect Listeria monocytogenes in food

EDTA chelation, high-dose vitamins/minerals may provide additional benefit for MI patients

Japan provides $2.6M to UNICEF to aid Pakistan's polio eradication program

Research: Digoxin reduces hospital admission of older, acute heart failure patients

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News